Policy | June 26, 2024
CCRAS hosts national consultative meet on traditional medicine
Signs MoUs with Shri Krishna Ayush University and Dabur India
Signs MoUs with Shri Krishna Ayush University and Dabur India
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
This tie-up will have no impact on any other brands of the company
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Renews GMP certifications for India and Malaysia sites
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
The company will now explore a buyer for its manufacturing site and exit in due course
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Subscribe To Our Newsletter & Stay Updated
